Role of Cathepsin K in Bone Invasion of Pituitary Adenomas: A Dual Mechanism Involving Cell Proliferation and Osteoclastogenesis
Authors:
Preprint
- 14 October 2024
- preprint
- Published by Springer Nature in Research Square
Abstract
Purpose: This study aimed to explore the regulation and mechanism of Cathepsin K (CTSK) in bone invasive pituitary adenomas (BIPAs). Experimental Design: A total of 1437 patients with pituitary adenomas were included and followed up. RNA sequencing, immunohistochemistry, and RT-PCR were used to analyze to detect CTSK expression. The impact of CTSK on cellular proliferation, bone matrix degradation, and osteoclasts differentiation was determined by gain/loss of function experiments in vitro and vivo. The exploration of signaling pathway was determined by molecular biology experiments. Results: Here, we reported a significant fraction (~10%) of pituitary adenoma patients developed bone invasion. Bone invasion was correleted with tumor recurrence. Shorter recurrence free survival was found in BIPA patients. CTSK expression was increased in BIPA patients and strongly associated with worse prognosis. Increased CTSK expression promoted pituitary adenoma cell proliferation via activation of mammalian target of rapamycin (mTOR) signaling pathway and bone invasion via increasing osteoclast differentiation in vitro and in vivo. CTSK inhibitor (odanacatib) could inhibit pituitary adenoma cell proliferation and bone invasion in vitro and in vivo. CTSK promoted osteoclast differentiation by promoting the RANKL expression of MC3T3-E1 cells through interaction with TLR4. Conclusion: CTSK may become a novel predictive biomarker and potential therapeutic target for BIPAs.Keywords
All Related Versions
This publication has 48 references indexed in Scilit:
- BAP1 phosphorylation-mediated Sp1 stabilization plays a critical role in cathepsin K inhibition-induced C-terminal p53-dependent Bax upregulationRedox Biology, 2022
- Overview of the 2022 WHO Classification of Pituitary TumorsEndocrine Pathology, 2022
- Targeting cathepsin K diminishes prostate cancer establishment and growth in murine boneJournal of Cancer Research and Clinical Oncology, 2019
- The Prognostic Roles of the Ki-67 Proliferation Index, P53 Expression, Mitotic Index, and Radiological Tumor Invasion in Pituitary AdenomasEndocrine Pathology, 2019
- Cathepsin K: The association between Cathepsin K expression and sphenoid sinus invasion of pituitary adenomasMedical Hypotheses, 2016
- Inhibition of Osteoclast Differentiation by Ginsenoside Rg3 in RAW264.7 Cells via RANKL, JNK and p38 MAPK Pathways Through a Modulation of Cathepsin K: An In Silico and In Vitro StudyPhytotherapy Research, 2015
- 14-3-3ζ Turns TGF-β’s Function from Tumor Suppressor to Metastasis Promoter in Breast Cancer by Contextual Changes of Smad Partners from p53 to Gli2Cancer Cell, 2015
- Hyaluronan inhibits TLR-4 dependent cathepsin K and matrix metalloproteinase 1 expression in human fibroblastsBiochemical and Biophysical Research Communications, 2013
- Inhibition of osteoclast differentiation and bone resorption by cathepsin K antisense oligonucleotidesMolecular Carcinogenesis, 2001
- Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and ActivationCell, 1998